Association of tumour necrosis factor alpha - 308 gene polymorphism with primary open-angle glaucoma in Chinese

Eye

Volumn 17, Issue 1, 2003, Pages 31-34

  Lin, H J ^a   Tsai, F J ^a   Chen, W C ^a   Shi, Y R ^a   Hsu, Y ^a   Tsai, S W ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Genetic polymorphism; Glaucoma; Tumour necrosis factor

Indexed keywords

ANTIGLAUCOMA AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHI SQUARE TEST; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE MAPPING; GENETIC MARKER; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TRABECULECTOMY; VOLUNTEER;

EID: 0037256477     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700227     Document Type: Article

References (20)

1. Van Buskirk EM. Glaucoma lexicon. Am J Ophthalmol 1990; 108: 730-731.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-393.
3. Anderson DR. Glaucoma: the damage caused by pressure. The XLVI Edward Jackson Memorial Lecture. Am J Ophthalmol 1989; 108: 485-495.
4. Hoskin HJ, Kass M. Primary open-angle glaucoma. In: Klein EA (ed). Becker-Shaffer's Diagnosis and Therapy of the Glaucomas, 6th edn. CV Mosby: St Louis, 1989, pp 277-307.
5. Tielsch J, Katz J, Singh K et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991; 134: 1102-1110.
6. Courtney RH, Hill EH. Hereditary juvenile glaucoma simplex. J Am Med Assoc 1931; 97: 1602-1609.
7. Francois J. Genetics and primary open angle glaucoma. Am J Ophthalmol 1966; 61: 652-665.
8. Lichter RP. Genetic clues to glaucoma's secrets. The L. Edward Jackson Memorial Lecture: part 2. Am J Ophthalmol 1994; 117: 706-726.
9. Beckman L, Frohlander N. Heterozygosity effects in studies of genetic markers and disease. Hum Hered 1990; 40: 322-329.
10. Wax MB. Is there a role for the immune system in glaucomatous optic neuropathy? Curr Opin Ophthalmol 2000; 11: 145-150.
11. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000; 32: 42-50.
12. Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glia cell exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20: 8693-8700.
13. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinase and tumor necrosis factor α in glaucomatous optic nerve head. Arch Ophthalmol 2000; 118: 666-673.
14. Roitt I, Brostoff J, Male D. Immunology In: Graham R, Frances B (eds). Cell-mediated Immune Reactions, 5th edn. CV Mosby: St Louis, 2000, pp 123-125.
15. Galbraith GH, Pendey JP. Tumor necrosis factor alpha (TNF-A) gene polymorphism in alopecia areata. Hum Genet 1995; 96: 433-436.
16. Patino GA, Sotillo PE, Modesto C, Sierrasesumaga L. Analysis of human tumour necrosis factor alpha (TNF α) gene promoter polymorphisms in children with bone cancer. J Med Genet 2000; 37: 789-791.
17. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukon Biol 1999; 66: 562-566.
18. Wilson AG, Symons JA, McDowell YL, Giovane FS, di Duff GW. Effects of a tumor necrosis factor (TNF α) promoter base transition on transcriptional activity. Br J Rheumatol 1994; 33: 89.
19. Allen RD. Polymorphism of the human TNF-alpha promoter - random variation or functional diversity? Mol Immunol 1999; 36(15-16): 1017-1027.
20. Agarwal P, Oldenburg Mc, Czarmeski JE et al. Comparison study for identifying promoter allelic polymorphism in interleukin 10 and tumor necrosis factor alpha genes. Diagn Mol Pathol 2000; 9: 158-164.